Clarifying Controversies in Cardiovascular Outcomes: Evidence Based Strategies for Setting and Achieving Glycemic Goals in Type 2 Diabetes
November 3, 2012
The Westin Bonaventure – San Francisco Ballroom
Los Angeles, CA
7:00pm – 9:30pm
This event is not part of the official Scientific Session 2012 as planned by the
AHA Committee on Scientific Sessions Programming.
Description
Life expectancy for a patient with Type 2 diabetes is substantially shorter than for one without this disease, largely because of the greater risk of cardiovascular disease associated with diabetes and lesser degrees of dysglycemia.
This activity will address knowledge gaps on interpreting and applying data that support the importance of glycemic control to improve cardiovascular outcomes in patients with Type 2 diabetes. Past and new clinical data will be examined and deciphered to foster appropriate tailoring of therapy to get patients to individual glycemic targets. Key experts will provide insight and guidance on applying these data to clinical practice to optimize glycemic control and improve cardiovascular outcomes.
Learning Objectives
1. Identify and evaluate the results of clinical trials that demonstrate the effect of glycemic control on cardiovascular outcomes in patients with T2D
2. Translate clinical trial data into practical, individualized strategies to establish and achieve glycemic goals in patients with T2D
3. Apply clinical evidence and guideline to determine which patients would benefit from aggressive glucose management
4. Intensify therapy in patients with uncontrolled hyperglycemia, considering patient characteristics and desires
5. Expand the role of the cardiologist in aggressive management of hyperglycemia with the goal of preventing CVD
Target Audience
Clinical Cardiologists, Endocrinologists, Internal Medicine Physicians, Nurses/Nurse Practitioners, Physician Assistants.
Course Directors
Steven Nissen, MD
|
Faculty
Leslie Cho, MD William C. Cushman, MD Robert H. Eckel, MD Lawrence A. Leiter, MD, FRCPC, FACP |
Agenda
| Saturday, November 3, 2012 | ||
| 7:00 pm | Buffet Dinner | |
| Moderator: Steven Nissen, MD | ||
| 7:30 pm | Welcome and Audience - Pre-Assessment (ARS System) | |
| 7:40 pm | The Critical Intersection of Diabetes and Cardiovascular Disease Leslie Cho, MD |
|
| 7:55 pm | How Do We Interpret Previous Studies on Glycemic Control and Cardiovascular Outcomes? William C. Cushman, MD |
|
| 8:15 pm | What is the Optimal Timing for Initiation of Insulin Therapy in Type 2 Diabetes? Robert H. Eckel, MD | 8:35 pm | What is the Potential for Current and Emerging Therapies to Improve Cardiovascular Outcomes? Lawrence A. Leiter, MD |
| 8:55 pm | Panel Discussion and Post Assessment with ARS | |
| 9:30 pm | Adjourn | |
Location
The Westin Bonaventure – San Francisco Ballroom
Los Angeles, CA
7:00pm – 9:30pm
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Americans with Disabilities Act
The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify Jamie Belkin at 216.932.3448 at least two weeks prior to the activity.
Grantors
The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from: sanofi-aventis U.S.
Faculty Disclosure
The Cleveland Clinic Foundation Center for Continuing Medical Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.
For further information or online registration assistance, please contact Jamie Belkin at 216.932.3448 or jamie@jamiebelkin.com.
| Category | Guest |
|---|---|
| Attendee | Complimentary |
